Discover 1,294 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
for
Acquired Factor X Deficiency
Location: Phoenix AZ, Rochester MN
Sponsor: Kedrion S.p.A.
Sex: All
Age: 18 - 70
Code: NCT06963216
Phase 3, Recruiting
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
for
High-grade Glioma, WHO Grade Ⅳ Glioma
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Tcelltech Inc.
Sex: All
Age: 18 - 70+
Code: NCT06482905
Phase 1, Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Phoenix AZ, Irvine CA, Duarte CA, Grand Junction CO,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06686771
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
for
Colorectal Cancer
Location: Phoenix AZ, Los Angeles CA, Lone Tree CO, Temple TX,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06948448
Phase 2, Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Phoenix AZ, La Jolla CA, Torrance CA, Los Angeles CA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Phoenix AZ, Scottsdale AZ, Las Vegas NV, La Jolla CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase 3, Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Phoenix AZ, Santa Monica CA, San Antonio TX, Houston TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06859762
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Phoenix AZ, La Jolla CA, Madera CA, Aurora CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase 2, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: Phoenix AZ, Gilbert AZ, Tucson AZ, San Diego CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Phoenix AZ, La Jolla CA, Irvine CA, Los Alamitos CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Phoenix AZ, Salt Lake City UT, Denver CO, Palo Alto CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07008118
Phase 1, Recruiting
Intent of Surgery for IPMN
for
Intraductal Papillary Mucinous Neoplasm
Location: Phoenix AZ, Houston TX, Rochester MN, Durham NC,
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT07216521
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Location: Phoenix AZ, San Diego CA, Vista CA, Encinitas CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06989437
Phase 2, Phase 3, Recruiting
PROMs After Pancreatectomy
for
Pancreas Neoplasms, Pancreatitis, Pancreatic Cyst
Location: Phoenix AZ, Tucson AZ
Sponsor: University of Arizona
Sex: All
Age: 18+
Code: NCT07173257
Recruiting
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Phoenix AZ, Tucson AZ, Houston TX, Rochester MN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07621718
Phase 3, Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Phoenix AZ, Gilbert AZ, Corona CA, Upland CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase 2, Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Phoenix AZ, Las Vegas NV, Farmington NM,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
for
Advanced Liver Cancer
Location: Phoenix AZ, Houston TX, Rochester MN, Tampa FL,
Sponsor: Abbisko Therapeutics Co, Ltd
Sex: All
Age: 18 - 70+
Code: NCT04906434
Phase 1, Recruiting
AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
for
Serious Illness, Existential Distress
Location: Phoenix AZ, Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07009210
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion